5-fluorouracil enhances the anti-tumor activity of the glutaminase inhibitor CB-839 against PIK3CA-mutant colorectal cancers

Autor Zhao, Yiqing, Feng, Xiujing, Chen, Yicheng, Selfridge, J. Eva, Gorityala, Shashank, Du, Zhanwen, Wang, Janet M., Hao, Yujun, Cioffi, Gino, Conlon, Ronald A., Barnholtz-Sloan, Jill S., Saltzman, Joel, Krishnamurthi, Smitha S., Vinayak, Shaveta, Veigl, Martina, Xu, Yan, Bajor, David L., Markowitz, Sanford D., Meropol, Neal J., Eads, Jennifer R., Wang, Zhenghe
Vydáno v Cancer Res (2020)